This All Facilities Letter (AFL) notifies GACHs and ASCs that perform endoscopic retrograde cholangiopancreatography (ERCP), and health care personnel responsible for these procedures and for the reprocessing of ERCP endoscopes (also called duodenoscopes), that the complex design of the duodenoscopes may impede effective reprocessing and has been associated with a number of outbreaks of infections of carbapenem-resistant Enterobacteriaceae (CRE).
On February 19, 2015, the U.S. Food and Drug Administration (FDA) issued a safety communication on this issue. The California Department of Public Health (CDPH) encourages all personnel involved with ERCP and reprocessing endoscopes to carefully review the alert at:
FDA - ERCP: Safety Communication
Send questions regarding this issue to CDPH’s Healthcare-Associated Infections Program at HAIProgram@cdph.ca.gov.
Original signed by Jean Iacino